*** Conﬁdential Treatment Requested and the Redacted Material has been separately ﬁled with the Commission.
(e) Limitations .
(i) Notwithstanding anything herein to the contrary, if any exercise of all or any portion of this
Warrant pursuant to Section 2, or any transfer of all or any portion of this Warrant pursuant to Section 11, requires the consent, approval,
order, waiver, exemption or authorization of, registration, declaration, filing or qualification with, certification, notice, application or
report to, or expiration of any waiting period (including under the Hart-Scott—Rodino Antitrust Improvements Act of 1976, as amended)
applicable to, any governmental authority, self—regulatory organization (including the NASDAQ Stock Market or any other applicable
national securities exchange) or any other third party as a condition to the lawful and valid exercise or transfer, as the case may be, of this
Warrant, then, in each case: (x) the Company shall not issue to the Holder any Warrant Shares upon such attempted exercise of this
Warrant, or such attempted transfer of this Warrant shall not be deemed effective, as applicable, unless and until any such consent,
approval, order, waiver, exemption or authorization has been obtained, any such registration, declaration, filing or qualification has been
made, any such certification, notice, application or report has been given or any such waiting period has expired, and then only to the
extent permitted thereunder; (y) each of the time periods provided in Section 2, Section 3 or Section 11, as applicable, for the
consummation of such exercise or transfer, as applicable, shall be suspended for the period of time during which any such consent,
approval, order, waiver, exemption, authorization, registration, declaration, filing, qualification, certification, notice, application, report or
waiting period expiration is being pursued; and (z) if and to the extent that any such suspension causes the consummation thereof to occur
after the Expiration Date, then such Expiration Date shall be extended to (A) in the event of an exercise, the date of consummation
thereof, and (B) in the event of a transfer, ten (10) days following the date of consummation thereof. The Company agrees to use its
commercially reasonable efforts to obtain, make or file (as applicable), or to assist the affected Person in obtaining, making or filing (as
applicable), any such consent, approval, order, waiver, exemption, authorization, registration, declaration, filing, qualification,
certification, notice, application, report or waiting period expiration and shall cooperate and use its commercially reasonable efforts to
respond as promptly as practicable to all inquiries received by it or by the affected Person from any governmental authority for initial or
additional information or documentation in connection therewith. Each of the Company and the Holder shall bear its own costs and
expenses in connection with this Section 3(e)(i).
(ii) Without limiting the generality of Section 3(e)(i), and notwithstanding anything herein to the
contrary, the Company shall not issue to the Holder any Warrant Shares upon any attempted exercise of this Warrant, if and to the extent
that, after giving effect to such issuance, such Holder (together with such Holder’s Affiliates, and any other Persons acting as a group
together with the Holder or any of the Holder’s Affiliates) would beneficially own in excess of >“**”"“% of the number of shares of
Common Stock outstanding immediately after giving effect to such issuance (the “ Maximum Aggggate Ownership Amount ”) or (ii)
control in excess of *****% of the total voting power of the Company’s securities outstanding immediately after giving effect to such
issuance that are entitled to vote on a matter being voted on by holders of the Common Stock (the “ MaximumAggLegateAlotingAmount
”), unless and until the Company obtains stockholder approval permitting such issuance in accordance with applicable rules of the
NASDAQ Stock Market (or any other applicable national securities exchange) (“ StockholderzApproval,"); proxide,d,, however,, that this
Section 3(e)(i) shall not apply to any exercise of this Warrant for which the Holder requests, and the Company agrees to, Net Cash